Abstract

ObjectivePatients with acute respiratory failure due to COVID-19 have a high likelihood of needing prolonged intubation and may subsequently require tracheotomy. Usually, the choice of technique (percutaneous dilatational tracheotomy [PDT] versus open surgical tracheotomy [OST]) depends on the preference of surgeons and patient-related factors. In case of COVID-19, airborne spread of viral particles and limited time of apnea must be considered in the choice of the safest technique. The aim of this study is to compare the complication rates and offer an assessment of relative risks and benefits of PDT versus OST in patients with severe COVID-19. MethodsWe performed a retrospective study considering 47 consecutive patients affected by severe acute respiratory distress syndrome due to SARS-CoV-2 infection, needing invasive mechanical ventilation and subsequent tracheostomy. This study was performed at the Intensive Care Unit of our tertiary referral center. Complication rates were analyzed. ResultsSeventeen patients underwent PDT and 30 patients were submitted to OST. Twenty-six patients (55.3%) had post-operative complications (local infection, hemorrhage, subcutaneous emphysema) with no significant difference between PDT and OST. ConclusionPDT and OST are characterized by similar postoperative complication rates in severe COVID-19 patients. These findings suggest that OST might be preferred if expert ENT surgeons are available, as PDT could result in longer apnea and exposure to generated aerosol. However, authors recommend considering either OST or PDT at the discretion of the medical staff involved, according to the personal experience of the operators performing the procedure.

Highlights

  • IntroductionFew data are reported concerning indications, timing, clinical results and percentage of complication in patients with COVID-19 treated by tracheotomy

  • PDT and OST are characterized by similar postoperative complication rates in severe COVID-19 patients

  • - any age and sex; - diagnosis of COVID-19 confirmed by nasopharyngeal/oropharyngeal swab; - severe acute respiratory distress syndrome (ARDS) due to COVID-19 infection; - treatment consisting in invasive mechanical ventilation (IMV) and subsequent tracheotomy; - follow up period ≥ 30 days

Read more

Summary

Introduction

Few data are reported concerning indications, timing, clinical results and percentage of complication in patients with COVID-19 treated by tracheotomy. The choice of technique (percutaneous dilatational tracheotomy [PDT] versus open surgical tracheotomy [OST]) depends on the preference of surgeons and patient-related factors, such as obesity and short neck. In case of patients affected by severe COVID-19, airborne spread of viral particles and limited time of apnea must be considered in the choice of the safest technique. We reported the complication rates of 47 consecutive COVID-19 patients with ARDS, requiring intubation and subsequent tracheotomy, treated at our tertiary referral center. The aim of this study is to compare the complication rates of the two techniques and offer an assessment of the relative risks and benefits of PDT versus OST performed in patients affected by severe COVID-19

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call